AU2003275038B2 - Kits and methods for assessing skin health - Google Patents

Kits and methods for assessing skin health Download PDF

Info

Publication number
AU2003275038B2
AU2003275038B2 AU2003275038A AU2003275038A AU2003275038B2 AU 2003275038 B2 AU2003275038 B2 AU 2003275038B2 AU 2003275038 A AU2003275038 A AU 2003275038A AU 2003275038 A AU2003275038 A AU 2003275038A AU 2003275038 B2 AU2003275038 B2 AU 2003275038B2
Authority
AU
Australia
Prior art keywords
gene
polymorphism
occurrence
disorder
encodes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003275038A
Other languages
English (en)
Other versions
AU2003275038A1 (en
Inventor
John R. Dephillipo
Robert P. Ricciardi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GeneLink Inc
Original Assignee
GeneLink Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GeneLink Inc filed Critical GeneLink Inc
Publication of AU2003275038A1 publication Critical patent/AU2003275038A1/en
Application granted granted Critical
Publication of AU2003275038B2 publication Critical patent/AU2003275038B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003275038A 2002-09-20 2003-09-19 Kits and methods for assessing skin health Ceased AU2003275038B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/247,935 2002-09-20
US10/247,935 US7211383B2 (en) 2001-04-05 2002-09-20 Kits and methods for assessing skin health
PCT/US2003/029529 WO2004026107A2 (en) 2002-09-20 2003-09-19 Kits and methods for assessing skin health

Publications (2)

Publication Number Publication Date
AU2003275038A1 AU2003275038A1 (en) 2004-04-08
AU2003275038B2 true AU2003275038B2 (en) 2009-09-03

Family

ID=32028981

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003275038A Ceased AU2003275038B2 (en) 2002-09-20 2003-09-19 Kits and methods for assessing skin health

Country Status (7)

Country Link
US (3) US7211383B2 (enExample)
EP (1) EP1581094A4 (enExample)
JP (3) JP2006513699A (enExample)
KR (1) KR20050057525A (enExample)
AU (1) AU2003275038B2 (enExample)
CA (1) CA2499390C (enExample)
WO (1) WO2004026107A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7054758B2 (en) * 2001-01-30 2006-05-30 Sciona Limited Computer-assisted means for assessing lifestyle risk factors
US20020146698A1 (en) * 2001-04-05 2002-10-10 Genelink, Inc. Kits and methods for assessing oxidative stress
US7211383B2 (en) * 2001-04-05 2007-05-01 Genelink, Inc. Kits and methods for assessing skin health
FI20040227L (fi) * 2004-02-13 2005-08-14 Jurilab Ltd Oy Menetelmä syövän, sepelvaltimotaudin ja aivohalvauksen riskin havaitsemiseksi
CN100412208C (zh) * 2006-04-07 2008-08-20 甄二真 基于基因多态性的皮肤美容保健方法
WO2009127073A1 (de) * 2008-04-18 2009-10-22 Gen Sod2 Foundation Auf ein individuum abgestimmte kosmetikzubereitung und verfahren zu deren herstellung
US20100304373A1 (en) * 2008-08-14 2010-12-02 Ricciardi Robert P Methods for Assessing the Susceptibility of a Human to Diminished Health and Wellness
KR101109043B1 (ko) * 2008-12-30 2012-02-09 사회복지법인 삼성생명공익재단 각질세포 또는 혈청 유래의 아토피성 피부질환 마커
JP2011115098A (ja) * 2009-12-04 2011-06-16 Nippon Menaade Keshohin Kk 加齢による皮膚明度の低下を予測する皮膚評価方法
GB2493141A (en) * 2011-07-19 2013-01-30 Gene Onyx Ltd Method of selecting a product using a DNA sample
KR101803980B1 (ko) * 2011-08-03 2017-12-04 주식회사 엘지생활건강 민감성 피부 타입 유전자 다형성 마커 및 이의 용도
GB2497766A (en) * 2011-12-20 2013-06-26 Gene Onyx Ltd Snp analysis to determine efficacy of skin care product
KR20160075501A (ko) * 2013-09-25 2016-06-29 더 프록터 앤드 갬블 캄파니 피부 케어 상담을 위한 방법 및 시스템
JP6328903B2 (ja) * 2013-10-10 2018-05-23 ジェネシスヘルスケア株式会社 皮膚関連遺伝子に基づく肌におけるリスク判別システム
CN108048423B (zh) * 2018-01-15 2020-05-08 江南大学 一种催化活性提高的菜豆环氧化物水解酶突变体及其应用
KR102346186B1 (ko) * 2019-12-23 2022-01-03 주식회사 테라젠바이오 피부 민감 위험도 예측용 바이오마커 및 이의 용도
KR20220137382A (ko) * 2021-04-02 2022-10-12 주식회사 엘지생활건강 주름 피부 타입 판단용 유전자 다형성 마커 및 이의 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3616923A1 (de) 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
US6013431A (en) 1990-02-16 2000-01-11 Molecular Tool, Inc. Method for determining specific nucleotide variations by primer extension in the presence of mixture of labeled nucleotides and terminators
US6004744A (en) 1991-03-05 1999-12-21 Molecular Tool, Inc. Method for determining nucleotide identity through extension of immobilized primer
CA2139667C (en) 1992-07-06 2005-03-29 Spencer B. Farr Methods and diagnostic kits for determining toxicity utilizing bacterial stress promoters fused to reporter genes
US5643623A (en) 1995-06-07 1997-07-01 Mars Incorporated Health food product and its uses
US6291171B1 (en) 1995-11-15 2001-09-18 Robert P. Ricciardi Kit for the non-invasive identification and collection of DNA
US5891622A (en) 1996-09-30 1999-04-06 Oxford Biomedical Research, Inc. Assessment of oxidative stress in vivo
US5955111A (en) 1996-10-08 1999-09-21 Hartford Hospital Methods and compositions for inducing production of stress proteins
US5920634A (en) * 1996-11-13 1999-07-06 Chiquette; Grace Rojan Activatable audio advertising display standard
JP3381053B2 (ja) 1996-11-29 2003-02-24 日研フード株式会社 酸化的ストレス判断解析表
US6133039A (en) 1998-02-09 2000-10-17 Washinton University In vivo method for determination of oxidative stress
US20020146698A1 (en) 2001-04-05 2002-10-10 Genelink, Inc. Kits and methods for assessing oxidative stress
EP1386001A4 (en) * 2001-04-05 2005-07-20 Genelink Inc KITS AND METHOD FOR ASSESSING OXIDATIVE STRESS
US7211383B2 (en) 2001-04-05 2007-05-01 Genelink, Inc. Kits and methods for assessing skin health

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Forsberg et al, oxidative Stress, Human genetics Variation, and Disease. Archives of Biochemistry and Biophysics, Vol 389, pages 84-93, 2001 *

Also Published As

Publication number Publication date
JP2006513699A (ja) 2006-04-27
US20130130247A1 (en) 2013-05-23
EP1581094A4 (en) 2008-04-23
EP1581094A2 (en) 2005-10-05
US7211383B2 (en) 2007-05-01
WO2004026107A3 (en) 2005-12-22
WO2004026107A2 (en) 2004-04-01
CA2499390A1 (en) 2004-04-01
JP2010263906A (ja) 2010-11-25
CA2499390C (en) 2013-08-20
US8313930B2 (en) 2012-11-20
US20070178518A1 (en) 2007-08-02
JP2013240351A (ja) 2013-12-05
KR20050057525A (ko) 2005-06-16
US20030073612A1 (en) 2003-04-17
AU2003275038A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
US8313930B2 (en) Kits and methods for assessing skin health
Sentı́ et al. Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase1 gene: the REGICOR study
JP2010263906A5 (enExample)
Park et al. Association study between catalase gene polymorphisms and the susceptibility to vitiligo in Korean population
US20140066327A1 (en) Kits and Methods for Assessing Oxidative Stress
Turaca et al. Novel GAA mutations in patients with Pompe disease
Patel et al. Analysis of the pattern, alliance and risk of rs1799752 (ACE I/D polymorphism) with essential hypertension
Bialecka et al. Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson’s disease
Hashimoto et al. The breakpoint cluster region gene on chromosome 22q11 is associated with bipolar disorder
US20070134709A1 (en) Usages of MTHFR gene polymorphisms in predicting homocysteine level, disease risk, and treatment effects and related methods and kit
Nagy et al. Schöpf-Schulz-Passarge syndrome resulting from a homozygous nonsense mutation in WNT10A
AU2002309543B2 (en) Kits and methods for assessing oxidative stress
AU2002309543A1 (en) Kits and methods for assessing oxidative stress
Funke et al. Genetic analysis of heme oxygenase-1 (HO-1) in German Parkinson’s disease patients
Muiras et al. Defending genomic stability over life span: a proposed role for PARP-1
JP2006191858A (ja) シミ、ソバカスまたは茶黒髪の予測方法並びにそれに基づく化粧品の選択方法
US20120164647A1 (en) Methods for assessing the susceptibility of a human to diminished health and wellness
Fortes et al. Polymorphisms of GSTM1 and GSTT1, sun exposure and the risk of melanoma: a case-control study
Smith et al. Melanocortin 1 receptor (MC1R) genotype influences erythemal sensitivity to psoralen–ultraviolet A photochemotherapy
Kotze et al. Molecular analysis reveals a high mutation frequency in the first untranslated exon of the PPOX gene and largely excludes variegate porphyria in a subset of clinically affected Afrikaner families
Abdel Rasol et al. The effect of catalase enzyme gene polymorphism A-21T (rs7943316) on epilepsy and its drug resistance after hypoxic ischemic brain injury
Cilingir et al. Glutathione S-Transferases M1/T1 and P1 Polymorphisms in Patients with Alopecia Areata
Cilingir et al. Glutathıone S-Transferases M1/T1 and P1 Polymorphisms in Patıents with Alopecia Areata
US20110027776A1 (en) Kits and methods for assessing antioxidant requirement of a human
KR20220137382A (ko) 주름 피부 타입 판단용 유전자 다형성 마커 및 이의 용도

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application
NA Applications received for extensions of time, section 223

Free format text: AN APPLICATION TO EXTEND THE TIME FROM 19 SEP 2008 TO 19 MAY 2009 IN WHICH TO PAY A CONTINUATION FEE HAS BEEN FILED .

NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO PAY A CONTINUATION FEE HAS BEEN EXTENDED TO 19 MAY 2009.

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired